Legato Capital Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $703 Million
- Q1 2025
A detailed history of Legato Capital Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 53,652 shares of CPRX stock, worth $1.3 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
53,652Holding current value
$1.3 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
360Shares Held
95.3MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$141 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$76.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$76.1 Million1.62% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.5B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...